<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?OLF?><front><journal-meta><journal-id journal-id-type="nlm-ta">Hematol Transfus Cell Ther</journal-id><journal-id journal-id-type="iso-abbrev">Hematol Transfus Cell Ther</journal-id><journal-title-group><journal-title>Hematology, Transfusion and Cell Therapy</journal-title></journal-title-group><issn pub-type="ppub">2531-1379</issn><issn pub-type="epub">2531-1387</issn><publisher><publisher-name>Associa&#x000e7;&#x000e3;o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7301062</article-id><article-id pub-id-type="publisher-id">S2531-1379(20)30072-9</article-id><article-id pub-id-type="doi">10.1016/j.htct.2020.06.003</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>COVID-19 as a trigger of acute chest syndrome in a pregnant woman with sickle cell anemia</article-title></title-group><contrib-group><contrib contrib-type="author" id="aut0005"><name><surname>Justino</surname><given-names>Caio Cesar</given-names></name><email>caiocjustino@gmail.com</email><xref rid="cor0005" ref-type="corresp">*</xref></contrib><contrib contrib-type="author" id="aut0010"><name><surname>Campanharo</surname><given-names>Felipe Favorette</given-names></name></contrib><contrib contrib-type="author" id="aut0015"><name><surname>Augusto</surname><given-names>Marina Nobrega</given-names></name></contrib><contrib contrib-type="author" id="aut0020"><name><surname>Morais</surname><given-names>Stela Cezarino de</given-names></name></contrib><contrib contrib-type="author" id="aut0025"><name><surname>Figueiredo</surname><given-names>Maria Stella</given-names></name></contrib><aff id="aff0005">Escola Paulista de Medicina, Universidade Federal de S&#x000e3;o Paulo (EPM UNIFESP), S&#x000e3;o Paulo, SP, Brazil</aff></contrib-group><author-notes><corresp id="cor0005"><label>&#x0204e;</label><italic>Corresponding author at</italic>: Escola Paulista de Medicina, Universidade Federal de S&#x000e3;o Paulo (UNIFESP), R. Dr. Diogo de Farias, 824, CEP 04037-002, Vila Clementino, S&#x000e3;o Paulo, SP, Brazil. <email>caiocjustino@gmail.com</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>18</day><month>6</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="epub"><day>18</day><month>6</month><year>2020</year></pub-date><history><date date-type="received"><day>27</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>11</day><month>6</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Associa&#x000e7;&#x000e3;o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Associa&#x000e7;&#x000e3;o Brasileira de Hematologia, Hemoterapia e Terapia Celular</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions></article-meta></front><body><sec id="sec0005"><title>Introduction</title><p id="par0005">Sickle cell disease (SCD) is a complex and life-threatening inherited blood disorder and one of most common genetic diseases worldwide.<xref rid="bib0075" ref-type="bibr"><sup>1</sup></xref> Pregnancy in SCD has been associated with increased maternal and fetal complications and a recent meta-analysis showed a strong association between SCD pregnancies and pulmonary complications.<xref rid="bib0080" ref-type="bibr"><sup>2</sup></xref>
</p><p id="par0010">The COVID-19 infection, caused by the SARS-CoV-2 coronavirus, can lead to an acute respiratory distress syndrome (ARDS) and multiple organ failure.<xref rid="bib0085" ref-type="bibr"><sup>3</sup></xref> Few reports have been published regarding the COVID-19 and pulmonary manifestations in SCD patients to date.<xref rid="bib0090" ref-type="bibr">4</xref>, <xref rid="bib0095" ref-type="bibr">5</xref>, <xref rid="bib0100" ref-type="bibr">6</xref>, <xref rid="bib0105" ref-type="bibr">7</xref>, <xref rid="bib0110" ref-type="bibr">8</xref> To our knowledge, no case of a pregnant woman with SCD and COVID-19 infection has been related until now.</p></sec><sec id="sec0010"><title>Case report</title><p id="par0015">This was a 35-year-old woman, with history of SCA, 28 weeks pregnant. Her prior history was acute chest syndrome (ACS) in 2012, pulmonary thromboembolism in 2017 with pulmonary hypertension (estimated PASP 47&#x000a0;mmHg), leg ulcers in 2012 and 2 previous pregnancies (the last one in 2017, complicated with preeclampsia). She had received the influenza vaccine on April 2, 2020.</p><p id="par0020">The patient presented to the emergency room on May 4, 2020, referring to myalgia and fever for the last 10 days and cough and dyspnea for the last seven days. At the presentation, dyspnea and hypoxia (SpO<sub>2</sub> 84%) were observed and corrected with 3&#x000a0;litters/minute of supplemental oxygen. She denied pain.</p><p id="par0025">Her initial blood exams were: red blood cells (RBCs) 1.7&#x000a0;&#x000d7;&#x000a0;10<sup>12</sup>/L; hemoglobin 6.4&#x000a0;g/dL; hematocrit 18.2%; WBC 14.5&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup>/L; neutrophils 11.2&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup>/L; lymphocytes 2.1&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup>/L; platelets 347&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup>/L; reticulocytes 308.9&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup>/L; reactive C-protein 100&#x000a0;mg/L, total bilirubin 2.6&#x000a0;mg/dL (unconjugated 1.55&#x000a0;mg/dL); lactate dehydrogenase 853&#x000a0;U/L; dimer-<sc>d</sc> 4620&#x000a0;mg/mL; creatinine 0.6&#x000a0;mg/dL; ferritin 4741&#x000a0;ng/mL. The chest CT showed bilateral pulmonary parenchyma ground-glass and consolidative pulmonary opacities with peripheral lung distribution (<xref rid="fig0005" ref-type="fig">Figure 1</xref>
), which was consistent with viral infection in the acute chest syndrome.<fig id="fig0005"><label>Figure 1</label><caption><p>Patient's CT showed typical findings of SARS-CoV-2 infection: bilateral pulmonary parenchyma ground-glass and consolidative pulmonary opacities with peripheral lung distribution.</p></caption><graphic xlink:href="gr1"/></fig></p><p id="par0030">The SARS-CoV-2 PCR nasopharyngeal swab testing was collected at admission (day 10 of symptoms) and she was conducted to the respiratory isolated intensive care unit (ICU). She was treated with ceftriaxone and azithromycin and received blood transfusion.</p><p id="par0035">She remained with the cough and fever for 2 days, but improvement in dyspnea and hypoxia was observed in this initial moment (SpO<sub>2</sub> 96% with 2&#x000a0;litters/minute supplemental oxygen). On the third day of hospitalization, she received positive testing for COVID-19 and was discharged from ICU, given her better clinical condition, being then transferred to the respiratory clinical unit.</p><p id="par0040">On ninth day of hospitalization (day 18 of symptoms), the SARS-CoV-2 PCR nasopharyngeal swab testing was repeated and resulted negative. At this time, the only symptom left was a minimal cough. She remained in blood transfusion therapy during hospitalization. Obstetric monitoring was provided at admission and during the entire hospitalization, with no complications detected, and maintaining good fetal mobility.</p></sec><sec id="sec0015"><title>Discussion</title><p id="par0045">The ACS is one of the leading causes of death in SCD adults.<xref rid="bib0075" ref-type="bibr"><sup>1</sup></xref> It can be triggered by bacterial infection and, although rare in adults, by viral infection.<xref rid="bib0115" ref-type="bibr"><sup>9</sup></xref> There are only a few studies about these infections causing ACS during the previous epidemics of H1N1 and SARS-CoV in the last decades, mainly in the pediatric population.<xref rid="bib0120" ref-type="bibr">10</xref>, <xref rid="bib0125" ref-type="bibr">11</xref> Strouse et al. showed that H1N1 virus had more chance of evolving into ACS with the incidence of as high as 34%.<xref rid="bib0125" ref-type="bibr"><sup>11</sup></xref> The literature is also scant on pulmonary infection by SARS-CoV-2 in SCD, considering its short time of history. Few case reports showed that the symptoms could be respiratory or even unspecific, presenting only with vaso-occlusive crisis. Overall, these results suggest a favorable evolution of the viral infection, even in the presence of SCD comorbidities.<xref rid="bib0090" ref-type="bibr">4</xref>, <xref rid="bib0130" ref-type="bibr">12</xref>
</p><p id="par0050">A recent review of COVID-19 in pregnant women showed some cases of severe maternal morbidity and perinatal deaths, although the majority of the cases had a good outcome.<xref rid="bib0135" ref-type="bibr"><sup>13</sup></xref> On the other hand, a recent paper showed that severe pulmonary complications are common in SCD pregnant women.<xref rid="bib0080" ref-type="bibr"><sup>2</sup></xref> In our report, however, the patient presented with respiratory symptoms and typical radiographic images of COVID-19, raising the hypothesis that the novel coronavirus infection was the trigger of the respiratory manifestation. Despite her previous history of pulmonary comorbidities and the current pregnancy, her clinical evolution was very favorable. As far as we know, not one case of ACS by the novel coronavirus in pregnant SCD patients was found in the literature.</p><p id="par0055">Despite the fact that it is a single-case observation, the evolution of the patient seems to corroborate the proposal of Hussain et al. that anemia, hemolysis and chronic inflammation, physiopathological characteristics of SCD, might have a favorable influence in the clinical course of COVID-19 infection in these patients.<xref rid="bib0100" ref-type="bibr"><sup>6</sup></xref> To enhance the knowledge of the scientific community in this field, we believe that physicians should be encouraged to access and submit their experience in data platforms such as &#x02018;Secure SCD Registry&#x02019;, coordinated by Panepinto et al., at the Medical College of Wisconsin, USA.<xref rid="bib0140" ref-type="bibr"><sup>14</sup></xref>
</p></sec><sec id="sec0020"><title>Conflicts of interest</title><p id="par0060">The authors declare no conflicts of interest.</p></sec></body><back><ref-list id="bibl0005"><title>References</title><ref id="bib0075"><label>1</label><element-citation publication-type="journal" id="sbref0075"><person-group person-group-type="author"><name><surname>Ware</surname><given-names>R.E.</given-names></name><name><surname>de Montalembert</surname><given-names>M.</given-names></name><name><surname>Tshilolo</surname><given-names>L.</given-names></name><name><surname>Abboud</surname><given-names>M.R.</given-names></name></person-group><article-title>Sickle cell disease</article-title><source>Lancet</source><volume>390</volume><issue>10091</issue><year>2017</year><fpage>311</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">28159390</pub-id></element-citation></ref><ref id="bib0080"><label>2</label><element-citation publication-type="journal" id="sbref0080"><person-group person-group-type="author"><name><surname>Inparaj</surname><given-names>S.</given-names></name><name><surname>Buckingham</surname><given-names>M.</given-names></name><name><surname>Oakley</surname><given-names>L.</given-names></name><name><surname>Seed</surname><given-names>P.T.</given-names></name><name><surname>Lucas</surname><given-names>S.</given-names></name><name><surname>Oteng-Ntim</surname><given-names>E.</given-names></name></person-group><article-title>Pulmonary complications for women with sickle cell disease in pregnancy: systematic review and meta-analysis</article-title><source>Thorax</source><year>2020</year></element-citation></ref><ref id="bib0085"><label>3</label><element-citation publication-type="journal" id="sbref0085"><person-group person-group-type="author"><name><surname>Down</surname><given-names>B.</given-names></name><name><surname>Kulkarni</surname><given-names>S.</given-names></name><name><surname>Ahmed Khan</surname><given-names>A.H.</given-names></name><name><surname>Barker</surname><given-names>B.</given-names></name><name><surname>Tang</surname><given-names>I.</given-names></name></person-group><article-title>Novel coronavirus (COVID-19) infection: what a doctor on the frontline needs to know</article-title><source>Ann Med Surg (Lond)</source><volume>55</volume><year>2020</year><fpage>24</fpage><lpage>29</lpage><comment>Epub ahead of print</comment></element-citation></ref><ref id="bib0090"><label>4</label><element-citation publication-type="journal" id="sbref0090"><person-group person-group-type="author"><name><surname>Odievre</surname><given-names>M.H.</given-names></name><name><surname>de Marcellus</surname><given-names>C.</given-names></name><name><surname>Ducou Le Pointe</surname><given-names>H.</given-names></name><name><surname>Romain</surname><given-names>A.S.</given-names></name><name><surname>Youn</surname><given-names>J.</given-names></name><name><surname>Taytard</surname><given-names>J.</given-names></name></person-group><article-title>Dramatic improvement after tocilizumab of severe COVID-19 in a child with sickle cell disease and acute chest syndrome</article-title><source>Am J Hematol</source><volume>1</volume><year>2020</year><pub-id pub-id-type="doi">10.1002/ajh.25855</pub-id><comment>Epub ahead of print</comment></element-citation></ref><ref id="bib0095"><label>5</label><element-citation publication-type="journal" id="sbref0095"><person-group person-group-type="author"><name><surname>De Luna</surname><given-names>G.</given-names></name><name><surname>Habibi</surname><given-names>A.</given-names></name><name><surname>Deux</surname><given-names>J.F.</given-names></name><name><surname>Colard</surname><given-names>M.</given-names></name><name><surname>Pham Hung d&#x02019;Alexandry d&#x02019;Orengiani</surname><given-names>A.L.</given-names></name><name><surname>Schlemmer</surname><given-names>F.</given-names></name></person-group><article-title>Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab</article-title><source>Am J Hematol</source><volume>13</volume><year>2020</year><pub-id pub-id-type="doi">10.1002/ajh.25833</pub-id><comment>Epub ahead of print</comment></element-citation></ref><ref id="bib0100"><label>6</label><element-citation publication-type="journal" id="sbref0100"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>F.A.</given-names></name><name><surname>Njoku</surname><given-names>F.U.</given-names></name><name><surname>Saraf</surname><given-names>S.L.</given-names></name><name><surname>Molokie</surname><given-names>R.E.</given-names></name><name><surname>Gordeuk</surname><given-names>V.R.</given-names></name><name><surname>Han</surname><given-names>J.</given-names></name></person-group><article-title>COVID-19 infection in patients with sickle cell disease</article-title><source>Br J Haematol</source><volume>189</volume><issue>5</issue><year>2020</year><fpage>851</fpage><lpage>852</lpage><pub-id pub-id-type="pmid">32314798</pub-id></element-citation></ref><ref id="bib0105"><label>7</label><element-citation publication-type="journal" id="sbref0105"><person-group person-group-type="author"><name><surname>Beerkens</surname><given-names>F.</given-names></name><name><surname>John</surname><given-names>M.</given-names></name><name><surname>Puliafito</surname><given-names>B.</given-names></name><name><surname>Corbett</surname><given-names>V.</given-names></name><name><surname>Edwards</surname><given-names>C.</given-names></name><name><surname>Tremblay</surname><given-names>D.</given-names></name></person-group><article-title>COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient</article-title><source>Am J Hematol</source><year>2020</year><pub-id pub-id-type="doi">10.1002/ajh.25809</pub-id><comment>Epub ahead of print</comment></element-citation></ref><ref id="bib0110"><label>8</label><element-citation publication-type="journal" id="sbref0110"><person-group person-group-type="author"><name><surname>Nur</surname><given-names>E.</given-names></name><name><surname>Gaartman</surname><given-names>A.E.</given-names></name><name><surname>van Tuijn</surname><given-names>C.F.</given-names></name><name><surname>Tang</surname><given-names>M.W.</given-names></name><name><surname>Biemond</surname><given-names>B.J.</given-names></name></person-group><article-title>Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19)</article-title><source>Am J Hematol</source><volume>95</volume><issue>6</issue><year>2020</year><fpage>725</fpage><lpage>726</lpage><pub-id pub-id-type="pmid">32267016</pub-id></element-citation></ref><ref id="bib0115"><label>9</label><element-citation publication-type="journal" id="sbref0115"><person-group person-group-type="author"><name><surname>Rees</surname><given-names>D.C.</given-names></name><name><surname>Williams</surname><given-names>T.N.</given-names></name><name><surname>Gladwin</surname><given-names>M.T.</given-names></name></person-group><article-title>Sickle-cell disease</article-title><source>Lancet</source><volume>376</volume><issue>9757</issue><year>2010</year><fpage>2018</fpage><lpage>2031</lpage><pub-id pub-id-type="pmid">21131035</pub-id></element-citation></ref><ref id="bib0120"><label>10</label><element-citation publication-type="journal" id="sbref0120"><person-group person-group-type="author"><name><surname>George</surname><given-names>A.</given-names></name><name><surname>Benton</surname><given-names>J.</given-names></name><name><surname>Pratt</surname><given-names>J.</given-names></name></person-group><article-title>The impact of the 2009 H1N1 influenza pandemic on pediatric patients with sickle cell disease</article-title><source>Pediatr Blood Cancer</source><volume>57</volume><issue>4</issue><year>2011</year><fpage>648</fpage><lpage>653</lpage><pub-id pub-id-type="pmid">21360656</pub-id></element-citation></ref><ref id="bib0125"><label>11</label><element-citation publication-type="journal" id="sbref0125"><person-group person-group-type="author"><name><surname>Strouse</surname><given-names>J.J.</given-names></name><name><surname>Reller</surname><given-names>M.E.</given-names></name><name><surname>Bundy</surname><given-names>D.G.</given-names></name><name><surname>Amoako</surname><given-names>M.</given-names></name><name><surname>Cancio</surname><given-names>M.</given-names></name><name><surname>Han</surname><given-names>R.N.</given-names></name></person-group><article-title>Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease</article-title><source>Blood</source><volume>116</volume><issue>18</issue><year>2010</year><fpage>3431</fpage><lpage>3434</lpage><pub-id pub-id-type="pmid">20656929</pub-id></element-citation></ref><ref id="bib0130"><label>12</label><element-citation publication-type="journal" id="sbref0130"><person-group person-group-type="author"><name><surname>McCloskey</surname><given-names>K.A.</given-names></name><name><surname>Meenan</surname><given-names>J.</given-names></name><name><surname>Hall</surname><given-names>R.</given-names></name><name><surname>Tsitsikas</surname><given-names>D.A.</given-names></name></person-group><article-title>COVID-19 infection and sickle cell disease: a UK centre experience</article-title><source>Br J Haematol</source><year>2020</year><pub-id pub-id-type="doi">10.1111/bjh.16779</pub-id><comment>Epub ahead of print</comment></element-citation></ref><ref id="bib0135"><label>13</label><element-citation publication-type="journal" id="sbref0135"><person-group person-group-type="author"><name><surname>Zaigham</surname><given-names>M.</given-names></name><name><surname>Andersson</surname><given-names>O.</given-names></name></person-group><article-title>Maternal and perinatal outcomes with COVID-19: a systematic review of 108 pregnancies</article-title><source>Acta Obstet Gynecol Scand</source><volume>7</volume><year>2020</year><pub-id pub-id-type="doi">10.1111/aogs.13867</pub-id><comment>Epub ahead of print</comment></element-citation></ref><ref id="bib0140"><label>14</label><element-citation publication-type="book" id="sbref0140"><person-group person-group-type="author"><name><surname>Panepinto</surname><given-names>J.A.</given-names></name><name><surname>Brandow</surname><given-names>A.M.</given-names></name><name><surname>Singh</surname><given-names>A.</given-names></name></person-group><chapter-title>Secure-SCD Registry. Surveillance epidemiology of coronavirus (COVID-19) under research exclusion</chapter-title><year>2020</year><publisher-name>Medical College of Wisconsin</publisher-name><publisher-loc>Wisconsin, USA</publisher-loc><comment><ext-link ext-link-type="uri" xlink:href="https://covidsicklecell.org/" id="intr0005">https://covidsicklecell.org/</ext-link> [accessed 06.08.20]</comment></element-citation></ref></ref-list></back></article>